Drug recall · February 12, 2020
Olmesartan Medoxomil Tablets 20 mg recall
Why: cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.
- Lots / codes
Lot #: 19122552, Exp 7/31/2021
- Quantity
- 192 Bottles
- Company
- Ascend Laboratories LLC, Parsippany, NJ
- Distribution
- Nationwide in the U.S.
- Initiated
- January 24, 2020 · Voluntary: Firm initiated
- Classified
- February 6, 2020
- Reported
- February 12, 2020
- Ended
- October 29, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olmesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.